Events

Event Date: 2021.01.21 Thu

Advanced Therapy Showcase in Tokyo#1

Life Science Innovation Network Japan (LINK-J) steps forward to launch a series of business partnering event “Advanced Therapy Showcase in Tokyo,” and is preparing for its first edition planned to be virtually held in Tokyo, Japan, on January 21, 2021.
The event features live-streaming plenary sessions, live-streaming company presentations, on-demand business pitches, and pre-arranged 1-on-1 business partnering meetings (1-on-1 meeting arrangements will open until February 17).
Any entities or individuals engaged in the field of advanced therapy, namely cell & gene therapy, regenerative medicine, etc., are encouraged to participate in the event to find suitable partner candidates for business development.

Click to open PDF

40700_ext_26_0

Date: January 21, 2021　8:15-19:00

Venue:

Online

Registration

(Opens an external site)

Registration due date

Registration tiers

		LINK-J members	members of the event supporters	LINK-J non-members
Tier 1： Live-streaming speakers	Entitled to give a real time live-streaming presentation for 20~30min (time is subject to change depending on the number of entries), In case the number of applications exceeds the live-streaming capacity, the organizing committee may ask a certain number of applicants to move down to the “on-demand exhibitors” tier, Eligible for 1-on-1 business meeting arrangements, and Eligible to access the live-streaming presentations and the on-demand business pitch exhibitions.	10,000 yen/person	15,000 yen/person	20,000 yen/person
Tier 2： On-demand presenters	Entitled to post up business pitch exhibition materials , Eligible for 1-on-1 business meeting arrangements, and Eligible to access the live-streaming presentations on-demand business pitch exhibitions.
Tier 3： General attendees	Eligible for 1-on-1 business meeting arrangements, and Eligible to access the live-streaming presentations and the on-demand business pitch exhibitions.

Registration deadline

Tier 1: Monday, November 30, 2020 JST
　→Extended to Friday, December 18, 2020 JST
Tier 2: Friday, January 8, 2021 JST
Tier 3:Friday, January 15, 2021 JST

List of Tier 3 participating companies (partial)

Mitsui Chemicals, Inc.
Otsuka Pharmaceutical Factory, Inc.
miibio, Inc.
SanBio Company Limited
Nippon Boehringer Ingelheim Co.,Ltd.
Daiichi Sankyo Co., Ltd.
Otsuka Pharmaceutical
Astellas Pharma Inc.
Santen Pharmaceutical Co., Ltd.
Fuji Chemical Industries Co.,Ltd.
Kyushu University Hospital
DyDo Pharma, inc.
Sumitomo Dainippon Pharma Co., Ltd.
Pharma Business Academy Ltd.
KOWA COMPANY, LTD.
Johnson and Johnson INNOVATION
ENEOS
JCR Pharmaceuticals Co., Ltd.
Western Univ. JPRO
NEC
and more

Official language：English

Program

Time	Program
8:30	Keynotes by Hideyuki Okano, M.D., Ph.D. (Chairman of the Board, LINK-J) Steven A. Goldman, M.D., Ph.D.（Professor of Neurology and Neuroscience/ Co-Director, Center for Translational Neuromedicine /University of Rochester Medical Center and the /University of Copenhagen Faculty of Health and Medical Sciences） Mr.Michael Lehmicke(Director, Science & Industry Affairs, ARM) Takanori Takebe, M.D., Ph.D.（Professor, Institute of Research, Tokyo Medical and Dental University /Director, Communication Design Center, Yokohama City University /Director of Commercial Innovation, Center for Stem Cell and Organoid Medicine, Cincinnati Children's Hospital Medical Center /Assistant Professor, Division of Gastroenterology, Hepatology and Nutrition and Division of Developmental Biology, Cincinnati Children's Hospital Medical Center） Yoshitsugu Shitaka, Ph.D.(Representative Director, Vice Chairperson FIRM,President of AIRM）
11:00-	Live-streaming company presentation (with a few breaks) Candidates Exopharm Ltd Glycostem Therapeutics B.V. Terumo BCT, Inc. Helixmith Co., Ltd Eyestem Research Private Limited TreeFrog Therapeutics PDC*line pharma SA Daiichi Sankyo Co., Ltd. Salipro Biotech AB
18:00-	Keynote by Philippe Fauchet Owen Smith（4Bio Capital） Nick Johnson, Ph.D., M.B.A.（Chief Strategy and Impact Officer Cell and Gene Therapy Catapult (CGTC))

Target

Product developers, novel technology providers, platform developers, and researchers who seek partners in Japan or elsewhere, and crave to excel in the field of advanced therapies such as;

regenerative medicine and tissue engineering,
cell therapy and gene-modified cell therapy,
gene therapy (in vivo/ex vivo) and gene editing therapy,
exosome based therapy,
nucleic acid medicine,
stem cell based drug discovery, etc.

Participation fee

20,000 yen/person for LINK-J non-members
10,000 yen/person for LINK-J members
15,000 yen/person for members of the event supporters

Any information disclosed in live-streaming presentations and on-demand business-pitch post-ups shall be regarded as non-confidential.

Target

以下のような領域で製品開発、技術開発にかかわり、より一層の発展に向けて国内外にパートナーを求める諸企業・諸団体、あるいは個人
再生医療及び組織工学
細胞治療及び遺伝子改変細胞治療
遺伝子治療（in vivo/ex vivo）
エクソソームベースの医療
核酸医療

Participation Fee

LINK-J非会員（一般）；20,000円/人
LINK-J会員；10,000円/人
優待登録；15,000円/人
（以下の団体メンバーに適用）
Alliance for Regenerative Medicine、Cell & Gene Therapy Catapult、FIRM、JETRO、Medcity、他

Organizer

LINK-J

Event Supporters


Alliance for Regenerative Medicine(ARM)	BIOCOM	Cell & Gene Therapy Catapult


Centre for Commercialization of Regenerative Medicine(CCRM)	Eurobiomed	Forum for Innovative Regenerative Medicine (FIRM)


Foundation for Biomedical Research and Innovation at Kobe（FBRI）	Japan External Trade Organization （JETRO）	Kanagawa


Kawasaki	Kyoto Research Park Corp.	MedCity


Medicen Paris	Osaka	SwedenBio


Yokohama

Contact

LINK-J
E-mail：f-mori@link-j.org